Research Articles

Deciphering the chemical profile and pharmacological mechanism of Jinlingzi powder (金铃子散) against bile reflux gastritis using ultra-high performance liquid chromatography coupled with Q exactive focus mass spectrometry, network pharmacology, and molecular docking

  • Hui REN ,
  • Lintao ZHAO ,
  • Kai GAO ,
  • Yuanyuan YANG ,
  • Xiaomin CUI ,
  • Jing HU ,
  • Zhiyong CHEN ,
  • Ye LI
Expand
  • 1 Institute of Traditional Chinese Medicine, Shaanxi Academy of Traditional Chinese Medicine, Xi'an 710003, China
    2 Department of Traditional Chinese Medicine, Xi'an Institute for Food and Drug Control, Xi'an 710054, China

Received date: 2022-06-22

  Accepted date: 2022-09-16

  Online published: 2023-09-08

Supported by

National Natural Science Foundation of China: a Feasibility Analysis of Porana Sinensis as a Substitute for Erycibes Caulis Based on "Variety, Quality, Property, Effect and Application" Integrated Research Model(81973419);Study on Efficient and Comprehensive Utilization of Leaf Resources, a Traditional non-Medicinal Part of Bergenia scopulosa T.P. Wang(2022SF-544);Exploring the in vivo Pharmacoactive Substances of Jinlingzi Powder Against Experimental Bile Reflux Gastritis using Based on LC-MS Technique(2018SF-302);Study on the in vivo Pharmacoactive Substances of Jinlingzi Powder in Preventing and Treating Liver Fibrosis in a Rat Model [No. 2019115613YX011SF044(13)

Abstract

OBJECTIVE: To elucidate the chemical profile and the pharmacological mechanism by which Jinlingzi powder (金铃子散, JLZP) treats bile reflux gastritis (BRG).
METHODS: A BRG model was established in rats by oral administration of the model solution. JLZP was orally administered for 35 d. Residual gastric rate and tumor necrosis factor (TNF)-α, interleukin (IL)-6, and gastrin levels in the serum were measured, and stomach tissues were collected for histopathological analysis. We used ultra-high performance liquid chromatography coupled with Q Exactive Focus mass spectrometry to identify the chemical ingredients in JLZP. Then, protein-protein interaction and herb-compound-target networks were constructed to screen potential bioactive compounds and targets. Kyoto Encyclopedia of Genes and Genomes pathway analysis was then performed to elucidate the pathway involved in the JLZP-mediated treatment of BRG. After constructing the core compound-target-pathway interaction network, molecular docking was performed to study the binding free energy of core bioactive compounds and two candidate targets [RAC-alpha serine/threonine-protein kinase (AKT1) and phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA)].
RESULTS: JLZP extracts significantly promoted gastric emptying, regulating the release of cytokines (TNF-α and IL-6) and improving gastrin secretion and mucosal repair. Fifty-six compounds were tentatively characterized in JLZP. Moreover, the network pharmacology and molecular docking results showed that alkaloids and flavonoids might be the bioactive compounds in JLZP that treat BRG. JLZP might improve mucosal repair during BRG progression by modulating the phosphatidylinositol-4,5-bisphosphate 3-kinase-protein kinase B, hypoxia inducible factor-1, mitogen-activated protein kinase, forkhead box O, TNF, and IL-17 signaling pathways.
CONCLUSIONS: We elucidated the chemical constituents and the pharmacological mechanism of JLZP in treating BRG and provided a basis for clinical application.

Cite this article

Hui REN , Lintao ZHAO , Kai GAO , Yuanyuan YANG , Xiaomin CUI , Jing HU , Zhiyong CHEN , Ye LI . Deciphering the chemical profile and pharmacological mechanism of Jinlingzi powder (金铃子散) against bile reflux gastritis using ultra-high performance liquid chromatography coupled with Q exactive focus mass spectrometry, network pharmacology, and molecular docking[J]. Journal of Traditional Chinese Medicine, 2023 , 43(6) : 1209 -1218 . DOI: 10.19852/j.cnki.jtcm.20230908.002

References

1. McCabe IV ME, Dilly CK. New causes for the old problem of bile reflux gastritis. Clin Gastroen Hepatol 2018; 16: 1389-92.
2. Chen HX, Sun JJ, Ma C. Clinical study of addition and subtraction therapy of Huagan Jian and Jinlinzi San to patients with bile reflux gastritis with syndrome of stagnation of liver and stomach heat. Zhong Guo Shi Yan Fang Ji Xue Za Zhi 2021; 27: 82-7.
3. Zhao YN, Xu CP. Etiology, pathogenesis, diagnosis and treatment of bile reflux gastritis. Shi Jie Hua Ren Xiao Hua Za Zhi 2018; 26: 1886-92.
4. Du X, Zhao L, Yang Y, et al. Investigation of the mechanism of action of Porana sinensis Hemsl. against gout arthritis using network pharmacology and experimental validation. J Ethnopharmacol 2020; 252: 112606.
5. Zhao X, Li J, Meng Y, Cao M, Wang J. Treatment effects of Jinlingzi powder and its extractive components on gastric ulcer induced by acetic acid in rats. Evid Based Complement Alternat Med 2019; 2019: 7365841.
6. Wang C, Yang J, Xiao B, Huang R. Comparison of analgesic and anti-inflammatory effect of Jinlingzisan compound and its single herbal. Ke Xue Ji Shu Yu Gong Cheng 2018; 18: 209-12.
7. Li W, Mao X, Wu H, et al. Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation. Phytomedicine 2020; 67: 153156.
8. Fu LL, Ding H, Han LF, et al. Simultaneously targeted and untargeted multicomponent characterization of Erzhi pill by offline two-dimensional liquid chromatography/quadrupole-orbitrap mass spectrometry. J Chromatogr A 2019; 1584: 87-96.
9. Xu L, Shang Z, Bo T, et al. Rapid quantitation and identification of the chemical constituents in Danhong injection by liquid chromatography coupled with orbitrap mass spectrometry. J Chromatogr A 2019; 1606: 460378.
10. Li S, Li X, Deng Q, et al. Simultaneous determination of eight constituents in Jiaoxiang Wenzhong Zhitong ointment by HPLC. Zhong Cheng Yao 2020; 42: 2853-6.
11. Liu Y, Zou Y, Liang J. Therapeutic effect and mechanism of Chaizhixiaji decoction on bile reflux gastritis rats. Yao Wu Ping Jia Yan Jiu 2017; 40: 1073-7.
12. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014; 6: 13.
13. Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform 2016; 54: 1.30.1-33.
14. David G, Aurélien G, Matthias W, et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 2014; 42: W32-8.
15. Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43: D447-52.
16. Sun M, Liu J, Lin C, Miao L, Lin L. Alkaloid profiling of the Traditional Chinese Medicine Rhizoma Corydalis using high performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry. Acta Pharm Sin B 2014; 4: 208-16.
17. Cui ZR, Li Y, Zhao ML, et al. MS diagnostic model and rapid distinguishing of bioactive limonoids in fruits of Melia toosendan using solid-phase extraction coupled with LC-MS/MS. Phytochem anal 2021; 32: 308-17.
18. Dong SH, Zhang CR, He XF, Liu HB, Wu Y, Yue JM. Mesendanins A-J, limonoids from the leaves and twigs of Melia toosendan. J Nat Prod 2010; 73: 1344-9.
19. Li Z, Xu J, Ju J, Zhu Y, Wang L. Chemical constituents from water extract of Toosendan Fructus by UPLC-ESI-Q-TOF-MS. Zhong Cao Yao 2015; 46: 496-501.
20. Wu SB, Su JJ, Sun LH, et al. Triterpenoids and steroids from the fruits of Melia toosendan and their cytotoxic effects on two human cancer cell lines. J Nat Prod 2010; 73: 1898-906.
21. Zhang Y, Tang CP, Ke CQ, Li XQ, Xie H, Ye Y. Limonoids from the fruits of Melia toosendan. Phytochemistry 2012; 73: 106-13.
22. Zhang Y, Tang CP, Ke CQ, Yao S, Ye Y. Limonoids and triterpenoids from the stem bark of Melia toosendan. J Nat Prod 2010; 73: 664-8.
23. Huang M, Zhang Y, Xu S, et al. Identification and quantification of phenolic compounds in Vitex negundo L. var. cannabifolia (Siebold et Zucc.) Hand.-Mazz. using liquid chromatography combined with quadrupole time-of-flight and triple quadrupole mass spectrometers. J Pharm Biomed Anal 2015; 108: 11-20.
24. Liu X, Fan X, Wang X, Liu R, Meng C, Wang C. Structural characterization and Screening of Chemical Markers of Flavonoids in Lysimachiae Herba and Desmodii Styracifolii Herba by ultra high-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry based metabolomics approach. J Pharm Biomed 2019; 171: 52-64.
25. Tian Y, Deng Y, Zhang W, Mu W. Sucrose isomers as alternative sweeteners: properties, production, and applications. Appl Microbiol Biotechnol 2019; 103: 8677-87.
26. Schubert ML, Rehfeld JF. Gastric peptides-gastrin and somatostatin. Compr Physiol 2019; 10: 197-228.
27. Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 2012; 119: 651-65.
28. Stefan RJ. Interleukin-6 family cytokines. C S H Perspect Biol 2018; 10: a028415.
29. Han YQ, Xu J, Gong SX, Zhang TJ, Liu CX. Chemical constituents and mechanism of Corydalis Rhizoma based on HPLC-QTOF/MS and G protein-coupled receptor analysis. Yao Xue Xue Bao 2016; 51: 1302-8.
30. Xie Y, Shi X, Sheng K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep 2019; 19: 783-91.
31. Sokolova O, Vieth M, Gnad T, Bozko PM, Naumann M. Helicobacter pylori promotes eukaryotic protein translation by activating phosphatidylinositol 3kinase/mTOR. Int J Biochem Cell Biol 2014; 55: 157-63.
32. Tong Y, Wang R, Liu X, et al. Zuojin pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis. J Ethnopharmacol 2021; 271: 113893.
33. Wang Y, Liu Y, Du X, Ma H, Yao J. The anti-cancer mechanisms of berberine: a review. Cancer Manag Res 2020; 12: 695-702.
34. Tong Y, Liu L, Wang R, et al. Berberine attenuates chronic atrophic gastritis induced by MNNG and its potential mechanism. Front Pharmacol 2021; 12: 644638.
35. Liu X, Hu Z, Shi Q, et al. Anti-inflammatory and anti-nociceptive activities of compounds from Tinospora sagittata (Oliv.) Gagnep. Arch Pharm Res 2010; 33: 981-7.
36. Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev 2017; 49: 139-57.
37. Tarabasz D, Kukula-Koch W. Palmatine: a review of pharmacological properties and pharmacokinetics. Phytother Res 2020; 34: 33-50.
38. Wu J, Zhang H, Hu B, et al. Coptisine from Coptis chinensis inhibits production of inflammatory mediators in lipopoly-saccharide-stimulated RAW 264.7 murine macrophage cells. Eur J Pharmacol 2016; 780: 106-14.
39. Hu J, Zhang WD, Liu RH, et al. Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities. Chem Biodivers 2006; 3: 990-5.
40. Jin L, Zhou S, Zhu S, et al. Dehydrocorydaline induced antidepressant-like effect in a chronic unpredictable mild stress mouse model via inhibiting uptake-2 monoamine transporters. Eur J Pharmacol 2019; 864: 172725.
41. Wen H, Zhang H, Wang W, Li Y. Tetrahydropalmatine protects against acute lung injury induced by limb ischemia/reperfusion through restoring PI3K/AKT/mTOR-mediated autophagy in rats. Pulm Pharmacol Ther 2020; 64: 101947.
42. Tian C, Liu X, Chang Y, Wang R, Yang M, Liu M. Rutin prevents inflammation induced by lipopolysaccharide in RAW 264.7 cells via conquering the TLR4-MyD88-TRAF6-NF-κB signalling pathway. J Pharm Pharmacol 2021; 73: 110-7.
43. Li L, Zhang XH, Liu GR, Liu C, Dong YM. Isoquercitrin suppresses the expression of histamine and pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-κB in human KU812 cells. Chin J Nat Med 2016; 14: 407-12.
44. Zhu M, Li J, Wang K, Hao X, Ge R, Li Q. Isoquercitrin inhibits hydrogen peroxide-induced apoptosis of EA.hy 926 cells via the PI3K/Akt/GSK3β signaling pathway. Molecules 2016; 21: 356.
Outlines

/